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Abstract
Strontium- and calcium-releasing, titanium-stabilised phosphate-based glasses with a controlled degradation rate are
currently under development for orthopaedic tissue engineering applications. Ca and/or Sr were incorporated at varying
concentrations in quaternary phosphate-based glasses, in order to promote osteoinduction. Ti was incorporated at a
fixed concentration in order to prolong degradation. Glasses of the general formula (P2O5)–(Na2O)–(TiO2)–(CaO)–
(SrO) were prepared via the melt-quench technique. The materials were characterised by energy-dispersive X-ray
spectroscopy, X-ray diffraction, 31P magic angle spinning nuclear magnetic resonance, Fourier transform infrared spec-
troscopy, differential thermal analysis and density determination. The dissolution rate in distilled water was determined
by measuring mass loss, ion release and pH change over a two-week period. In addition, the cytocompatibility and
alkaline phosphatase activity of an osteoblast-like cell line cultured on the surface of glass discs was assessed. The glasses
were shown to be amorphous and contained Q1, Q2 and Q3 species. Fourier transform infrared spectroscopy revealed
small changes in the glass structure as Ca was substituted with Sr and differential thermal analysis confirmed a decrease in
crystallisation temperature with increasing Sr content. Degradation and ion release studies also showed that mass loss
was positively correlated with Sr content. These results were attributed to the lower electronegativity of Sr in com-
parison to Ca favouring the formation of phosphate-based mineral phases. All compositions supported cell proliferation
and survival and induced at least 2.3-fold alkaline phosphatase activity relative to the control. Glass containing 17.5mol%
Sr had 3.6-fold greater alkaline phosphatase activity than the control. The gradual release of Ca and Sr supported
osteoinduction, indicating their potential suitability in orthopaedic tissue engineering applications.
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Introduction
Osteoporosis is a progressive bone disease, most
common in post-menopausal women, in which the deli-
cate balance of bone turnover is disrupted. The porous
microarchitecture of osteoporotic bone is caused by
simultaneous down-regulation of bone mineral depos-
ition by osteoblasts and up-regulation of mineral
resorption by osteoclasts. This results in high suscepti-
bility to bone fractures and is a major cause of morbid-
ity and mortality.1
The cost of orthopaedic surgery is a signiﬁcant and
increasing ﬁnancial burden, with osteoporosis-related
fracture alone accounting for estimated direct costs of
EUR37 bn in the EU in 20102 and USD17 bn in the
US in 2005.1,3 These ﬁgures are predicted to increase by
25 and50%, respectively, by 2025, due to ageing and
increasingly diverse population demographics. There is
subsequently a high demand for novel biomaterials
which induce bone formation for the surgical treatment
of fractures and for other orthopaedic and dental tissue
engineering applications. A wide range of orthopaedic
materials have been developed over the past 50 years for
the treatment of fractures caused by osteoporosis, con-
genital disorders such as osteogenesis imperfecta and
cleft palate, or injury. One such class of materials is
phosphate-based glasses, which are advantageous over
silica-based glasses due to their more controllable dissol-
ution rate.2,4 While silica-based glasses typically take
several years to dissolve,5 the dissolution rate of phos-
phate-based glasses can be varied over several orders of
magnitude, from 2 h to >1 year, via the addition of
oxide modiﬁers, such as TiO2, which increase the stabil-
ity of network crosslinks.6 This in turn enables precise
tuning of the degradation rate for controlled release of
ions that promote or inhibit speciﬁc cellular process,7
e.g. induction of bone formation (Ca2þ, Sr2þ, polyphos-
phates)6,8,9; promotion of vascularisation and angiogen-
esis (Co2þ andCu2þ)10,11 and antimicrobial action (Agþ,
Cu2þ, F, Zn2þ).12,13 Furthermore, the tuneable degrad-
ation rate of phosphate-based glasses can be targeted to
match that of tissue turnover, e.g. bone resorption and
deposition, for promotion of osseointegration.
Combined with their similar composition to the mineral
phase of bone, this makes phosphate-based glasses suit-
able for various orthopaedic tissue engineering applica-
tions, including coatings for dental, maxillofacial and
orthopaedic implants and scaﬀolds for bone tissue
engineering.
Ca and Sr are widely known to inﬂuence osteoinduc-
tion and osteogenesis.14 The use of Sr in biomaterials
has gained particular interest over the last decade, due
to its apparent dual anabolic and anti-catabolic mech-
anisms of action.15 Through these synergistic processes,
Sr simultaneously upregulates mineral deposition by
osteoblasts and inhibits bone resorption by osteoclasts,
resulting in a net gain in mineralised tissue. The oral
drug strontium ranelate has been notably successful in
reducing hip and vertebral fractures in post-menopau-
sal women by improving bone mineral density.1,16–19
Although recommendations regarding its use have
recently changed, due to a small but signiﬁcant
increased risk of adverse cardiovascular disorders in
patients with cardiovascular contraindications, data
do not indicate any detrimental eﬀects in patients with-
out such conditions.20 Given that this process appears
to be induced by Sr2þ cations, the controlled delivery
of Sr2þ in bone tissue engineering applications is
therefore considered to have potentially therapeutic
eﬀects.7,14,21–23
The eﬀect of strontium content has previously been
investigated in silica-based melt-quench glasses.
Increasing Sr content in glass discs with the formula
(SiO2)46.5–(P2O5)1–(Na2O)26.4–(CaO)(23.1-x)–(SrO)x
(x¼ 0, 2.3, 11.5 or 23.1) (mol%) resulted in increased
cell proliferation and normalised alkaline phosphatase
(ALP) activity in human osteosarcoma cell line Saos-2.
Sr content also inhibited calcium phosphate resorption
and reduced tartrate-resistant acid phosphatase activity
in a dose-dependent manner, suggesting a dual action
mechanism of released Sr2þ ions.24 Recently, an in vivo
study demonstrated the eﬀectiveness of a Sr-containing
bioactive glass with the formula (CaO)3.18–(SiO2)51.45–
(MgO)8.67–(Na2O)4.62–(K2O)4.62–(ZnO)3.47–(P2O5)5.20
(mol%) in inducing bone formation in rabbits.23
Furthermore, in a series of studies, our group devel-
oped complex ternary, quaternary and quinternary
phosphate-based glasses containing 0, 1, 3 and
5mol% Sr and 0, 3 and 5% Ti.6,8,9 Increasing Ti con-
tent resulted in a direct increase in glass stability and
cytocompatibility, as expected. More complex trends,
however, were observed in the case of Sr. A threshold
of 1mol% appeared to disrupt the glass network and
cause substantially more rapid degradation than was
observed in Sr-free compositions. This reduced the via-
bility of cells grown on the surface of the materials.
Increasing Sr content to 3 or 5mol%, however, resulted
in a lesser increase in degradation and an increase in
cytocompatibility.6,9 These trends were attributed to
disruption of the glass network caused by the larger
atomic radius of Sr2þ than Ca2þ (eﬀective radii of
1.18 and 1.00 A˚, respectively).6
In the present study, quaternary and quinternary
phosphate-based glasses with Ti ﬁxed at 5mol% and
substantially higher Sr content (up to 35mol%, com-
pared with 5mol% in previous studies) were prepared
via the melt-quench technique, in order to further inves-
tigate the eﬀects of Sr content. The novel glasses had
the formula (P2O5)50–(Na2O)10–(TiO2)5–(CaO)(35-x)–
(SrO)(x) (x¼ 0, 3.5, 17.5 or 35) (mol%). These compos-
itions had 0, 10, 50 and 100mol% CaO:SrO
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substitution. The physical properties of each glass com-
position were characterised using energy-dispersive
X-ray spectroscopy (EDX), X-ray diﬀraction (XRD),
31P magic angle spinning nuclear magnetic resonance
(31P MAS-NMR), Fourier transform infrared spectros-
copy (FTIR), diﬀerential thermal analysis (DTA) and
density determination. The degradation of the materials
was determined by measuring weight loss, ion release
and pH change upon storage in distilled water over a
period of two weeks. Cytocompatibility and ALP activ-
ity of osteoblast-like cell line MG-63 were also assessed
over the same period.
Materials and methods
Materials
The following chemical precursors were used without
further puriﬁcation: diphosphorus pentoxide (P2O5,
98%, VWR, Lutterworth, UK), sodium dihydrogen
phosphate (NaH2PO4, 99%, VWR), titanium oxide
(TiO2, 99%, VWR), calcium carbonate (CaCO3,
98.5%, VWR) and strontium carbonate (SrCO3,
98.5%, BDH Laboratory Supplies, Poole, UK).
Glass preparation
The precursors were mixed thoroughly (Stomacher 400
Circulator, Seward, Worthing, UK) according to the
four compositions summarised in Table 1. The mixtures
were placed in a 200ml Pt/10%Rh crucible (type 71040,
Johnson Matthey, Royston, UK) and heated to 1350C
for 4 h (RHF 1500, Carbolite, Hope, UK), after which
the melted glass was poured into a preheated graphite
cylindrical mould (ø 15mm) and heated at 420C for
1 h. The glass was then left to gradually cool to room
temperature overnight, in order to remove residual
stress. Glass rods were then released from the mould
and cut into 2mm thick discs (Accutom 50 electric dia-
mond saw, Struers, Catcliﬀe, UK). The glass was
ground to form a powder for XRD, 31P MAS-NMR
and FTIR analyses (MM 301 Mixer Mill, Retsch
GmbH, Hope, UK).
Materials characterisation
EDX. EDX (Inca 300, Oxford Instruments, Abingdon,
UK) was used to determine the exact compositions of
the prepared samples. SEM (XL30, Philips, Eindhoven,
Netherlands) was operated at 20 kV, spot size 5 and a
working distance of 10mm, in order to identify the par-
ticular elements and their relative proportions with
EDX from the scanned area.
Density determination. The density of each composition
was measured using an analytical balance and density
determination apparatus according to Archimedes’
principle (AG 204 & MS-DNY-43, Mettler Toledo,
Beaumont Leys, UK). Ethanol (99.8%, Sigma-
Aldrich, Gillingham, UK) was used as the immersion
vehicle, since phosphate-based glasses are water
soluble. The density of the glass discs (n¼ 3) was
calculated using equation (1)
glass ¼ mair
mair methonal  ethonal ð1Þ
where glass, ethanol, mair and methanol are the density of
the specimen (g/cm3), density of ethanol at the tempera-
ture at which the measurement was performed, mass (g)
of the specimen in air and mass of the specimen under
ethanol, respectively.
XRD. The crystallinity of each glass composition was
determined by XRD (D8 Advance Diﬀractometer,
Bru¨ker, Coventry, UK). Specimens of glass powder
were positioned in a ﬂat plate geometry and Ni-ﬁltered
Cu Ka radiation was used. Data were collected using a
Lynx Eye detector with a step size of 0.02 over an
angular range of 2y¼ 10–100 and a count time of 12 s.
31P MAS-NMR. The network structure of each glass
composition was determined by 31P MAS-NMR
(VNMRS-400 Spectrometer, Varian, Crawley, UK).
Spectra of each glass composition were recorded at
161.87MHz and referenced to the resonance of the sec-
ondary reference ammonium dihydrogen phosphate
(NH4H2PO4) at 0.9 ppm (relative to 85% H3PO4 solu-
tion at 0 ppm). Specimens of glass powder were loaded
into a 4mm (rotor o.d.) magic angle spinning probe.
Between 20 and 88 spectra were obtained for each spe-
cimen using direct excitation with a 90 pulse and 60 s
recycle delay at ambient probe temperature (25C)
and at a sample spin rate of 10 kHz. Spectra were pro-
cessed using DM-ﬁt software.
FTIR. The infrared band assignment of each glass com-
position was determined by FTIR (FT-IR 2000 and
Timebase software, Perkin Elmer, Seer Green, UK).
Specimens of glass powder were placed on an
Table 1. Theoretical glass compositions.
Glass
code
Full theoretical
composition
Concentration (mol%)
P2O5 Na2O TiO2 CaO SrO
Sr0 P50Na10Ti5Ca35 50 10 5 35 0
Sr3.5 P50Na10Ti5Ca31.5Sr3.5 50 10 5 31.5 3.5
Sr17.5 P50Na10Ti5Ca17.5Sr17.5 50 10 5 17.5 17.5
Sr35 P50Na10Ti5Sr35 50 10 5 0 35
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attenuated total reﬂectance accessory (Golden Gate,
Specac, Orpington, UK) and spectra in the range of
2000–600 cm1 were acquired at room temperature in
absorbance mode.
DTA. The thermal properties of each glass composition
were determined by DTA (Labsys, Setaram, Caluire,
France). The study was carried out on 50mg of each
glass composition from 300C up to 1200C at a heat-
ing rate of 20C/min, in order to determine the glass
transition (Tg), crystallisation (Tc) and melting (Tm)
temperatures. Blank run was also carried out to base-
line correct the data.
Material degradation
The degradation of the glass discs (n¼ 3) was quantiﬁed
after one, four, seven and 14 days storage in 25ml deio-
nised water (pH 7.0 0.1) bymeasuring themass change
of the specimens, the ion release and the pH change of
the solution. At each time point, specimen extracts were
collected for pH change (Orion Star pH Meter, Thermo
Scientiﬁc, UK) and ion chromatography measurements.
Glass samples were dried and weighed at each time point
for determination of mass change, before being trans-
ferred to fresh deionised water. Mass change was calcu-
lated according to equation (2)
m ¼m0 mt
A
ð2Þ
where m, m0, mt and A are the change in mass (g),
initial mass, mass at speciﬁc time point and surface area
of the specimen (cm2), respectively.
Ion chromatography. Distilled water containing glass dis-
solution products were collected at each time point and
the release of cations (Naþ, Ca2þ and Sr2þ) and anions
(PO34 , P2O
4
7 , P3O
3
9 and P3O
5
10 ) was quantiﬁed using
ion chromatography, as previously described.25 Prior to
cation analysis, liquid specimens were passed through
OnGaurd IIA ﬁlters (Dionex, Thermo Scientiﬁc, Hemel
Hempstead, UK) and elution was performed within
20mM methanesulfonic acid (Sigma-Aldrich). Cations
and anions were analysed under suppressed conductiv-
ity (ICS-1000 system equipped with CS12A column and
ICS-2500 system equipped with AS16 column, respect-
ively, Dionex). Isocratic separation was applied
for analysis of anions with a linear KOH gradient of
30–50mM over a 35min period (EG50 eluent gener-
ator) and data were extrapolated from standard
curves (Chromelon software, Dionex), prepared using
commercial standard solutions (Dionex) and results
expressed as cumulative release per unit area of the
individual specimen tested (cm2).
Cell studies
Cell culture. Human osteoblast-like osteosarcoma cell
line (MG-63, European Collection of Cell Cultures,
Porton Down, UK) was cultured under standard con-
ditions (37C, 95% air, 5% CO2, 95% relative humid-
ity) in Dulbecco’s modiﬁed Eagle medium (Gibco, Life
Technologies, Paisley, UK) supplemented with 10%
foetal bovine serum (Gibco) and 1% penicillin/strepto-
mycin (PAA Laboratories, GE Healthcare, Chalfont
St. Giles, UK).
Cytocompatibility assay. Cytocompatibility was assessed
in accordance with ISO 10993-5:2009.26 Glass
discs were sterilised under ultraviolet light for 10min
on each side, before being transferred to 48 well
plates. MG-63 cells were seeded on top of the discs at
a density of 30,000 cells/cm2 in 1ml medium. The con-
trol consisted of cells seeded directly on tissue culture
plastic (TCP) of the same surface area. Cell cul-
ture medium was replenished every three days.
Cytocompatibility was assessed after one, four, seven
and 14 days. At each time point, cells were seeded at
various densities, 2 h prior to the assay, for preparation
of standard curves. The medium was then aspirated
from the samples and standards and replaced with
1ml medium containing 10 vol% water soluble tetrazo-
lium salt-8 (WST-8, Cell Counting Kit-8, Sigma
Aldrich, Gillingham, UK). WST-8 is a pink substrate
which is metabolised by mitochondria to form an
orange formazan product. After 80min incubation at
37C, absorbance at 460 nm (with a reference wave-
length of 650 nm) was measured (Inﬁnite M200,
Tecan, Ma¨nnedorf, Switzerland). Apparent cell density
of the samples was then extrapolated from the standard
curves.
ALP activity. The ALP activity of cells cultured on glass
discs for four, seven or 14 days was analysed using a
p-nitrophenyl phosphate-based assay (SensoLyte pNPP
Alkaline Phosphatase Assay Kit, AnaSpec, Seraing,
Belgium). Medium was aspirated from end-point sam-
ples from the cytocompatibility study and the cells were
gently rinsed twice using 300 ml assay buﬀer. The cells
were then lysed by freeze–thawing (two cycles of 80C
for 20min, followed by 37C for 12min) in 300ml assay
buﬀer containing 0.2 vol% Triton X-100. After agita-
tion at 4C for 10min, the contents of the cells were
collected by repeatedly rinsing the surface using the
lysate and centrifuging (2500 g, 10min, 4C). The
supplied ALP standard was diluted to various concen-
trations for the preparation of a standard curve. Fifty
microlitres of each supernatant or standard was added
to 50 ml pNPP substrate in a 96-well plate. After 30min
incubation at 37C, absorbance was measured at
405 nm. ALP concentration was extrapolated from
4 Journal of Biomaterials Applications 0(0)
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the standard curve and normalised to the cell densities
obtained using the WST-8 assay.
Results
Material properties
EDX. The measured compositions of prepared glasses
by EDX are reported in Table 2. The results showed a
reduction of around 3mol% P2O5 content compared to
the theoretical values. This reduction was accompanied
by a concomitant increase in the percentage content of
the other oxides to compensate.
Density. An increase in Sr content directly correlated
with an increase in glass density (Figure 1), with den-
sities ranging from 2.6 g/cm3 (Sr0) to 3.0 g/cm3 (Sr35).
XRD. Figure 2 shows the XRD spectra of the glasses.
A broad peak at 2y values of 20–40 conﬁrmed the
amorphous nature of all glass samples and indicated
that they lacked any detectable crystalline phase.
31P MAS-NMR. The 31P MAS-NMR spectra of the glass
samples are displayed in Figure 3 and the peak
parameters are summarised in Table 2. The resonances
in 31P MAS-NMR spectra are assigned to various Qn
species, where n represents the number of bridging
oxygen atoms in the PO34 group that are connected
to other such phosphate tetrahedra to form a net-
work.27 Peaks in the range of 8.3 to 8.9 ppm are
attributed to Q1 phosphate units, while peaks in the
range of 23.6 to 25.7 ppm and 33.6 to
34.2 ppm correspond to the Q2 and Q3 species,
respectively.8,28,29
FTIR. The FTIR spectra of the phosphate-based glass
powders are presented in Figure 4 and their infrared
band assignments are summarised in Table 4, according
to previous studies on phosphate-based glasses.28,30,31
The broad peaks at 740 cm1 can be assigned to
150 100 50 0 –50 –100 –150 –200
Concentration (ppm)
Sr35
Sr17.5
Sr3.5
Sr0
Figure 3. 31P MAS-NMR spectra of Ti-stabilised phosphate-
based glasses with varying Ca and Sr content. Peaks in the range
of 8.3 to 8.9 ppm, 23.6 to 25.7 ppm and 33.6 to
34.2 ppm correspond to Q1, Q2 and Q3 phosphate species,
respectively.
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Figure 1. Density of Ti-stabilised phosphate-based glasses with
varying Ca and Sr content. Increasing Sr content correlated with
increasing density, from 2.6 g/cm3 (Sr0) to 3.0 g/cm3 (Sr35). Error
bars are SD (n¼ 3).
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Figure 2. XRD spectra of Ti-stabilised phosphate-based glasses
with varying Ca and Sr content. No crystalline phase was
detected, indicating the amorphous nature of the glasses.
Table 2. Measured compositions of prepared glasses, deter-
mined by EDX.
Glass
code
Concentration (mol%)
P2O5 Na2O TiO2 CaO SrO
Sr0 46.4 (1.1) 10.9 (0.8) 5.8 (0.6) 36.9 (0.9) 0
Sr3.5 46.7 (1.0) 10.7 (0.9) 5.7 (0.7) 32.8 (0.8) 4.1 (0.5)
Sr17.5 47.3 (1.2) 10.8 (0.7) 5.5 (0.5) 18.3 (0.9) 18.1 (0.6)
Sr35 47.1 (1.1) 10.8 (0.7) 5.6 (0.5) 0 36.5 (0.6)
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symmetrical stretching s (P–O–P), while the peaks at
900 and 980 cm1 correspond to as (P–O–P) and s
(PO3)
2, respectively. The peaks at 1100 and 1250 cm1
can also be assigned to as (PO3)
2 and as (PO2)
,
respectively.
DTA. Figure 5 shows the DTA spectra of the glasses.
The Tg of the glasses was in the range of 468–483
C and
there was no clear trend observed as the Sr content was
increased. The Tc, however, declined from a single
exothermic peak at 761.9C for Sr0 to two distinct crys-
tallisation peaks at Tc values of 647 and 701
C for Sr35.
A similar trend was observed for the Tm values with
decline from a broad peak at 850C for Sr0 to a sharp
peak at 752C for Sr35.
Glass degradation and ion release
The mass loss and pH change of glass specimens is
shown in Figure 6. As Sr content was increased, a con-
comitant increase in degradation was observed, with
mass loss after 14 days ranging from 16.4mg/cm3
(Sr0) to 26.7mg/cm3 (Sr35). The diﬀerence in mass
loss between Sr0 and Sr35 was approximately double
that of the diﬀerence between Sr0 and Sr17.5, indicat-
ing that mass loss was roughly proportional to Sr con-
tent. The pH of the storage vehicle decreased
continuously over the course of 14 days for Sr0. By
increasing Sr content, the eﬀect on pH was lessened,
with Sr35 causing minimal reduction in pH.
The cumulative release of cations (Naþ, Ca2þ and
Sr2þ) and anions (PO34 , P2O
4
7 , P3O
3
9 and P3O
5
10 ) is
presented in Figures 7 and 8, respectively. The concen-
tration of Naþ present in solution decreased as a func-
tion of increasing Sr content in the glass. This
relationship, however, inversely correlated with weight
loss (Figure 6(a)). Sr2þ release was found to increase as
Sr content in the glass increased. Likewise, Ca2þ release
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Figure 5. DTA spectra of Ti-stabilised phosphate-based glasses
with varying Ca and Sr content. Tg was similar (468–483
C) for
all compositions. Tc declined from a single exothermic peak
(761.9C; Sr0) to two distinct crystallisation peaks (647, 701C;
Sr35). Tm similarly declined from a broad peak (850
C; Sr0) to a
sharp peak (752C; Sr35).
Table 3. 31P MAS-NMR. Peak parameters of the prepared
samples.8,32
Theoretical
composition
Position
(ppm,
0.2)
Qi
species
Line width
(ppm, 0.2)
Abundance
(%, 1.0)
P50Na10Ti5Ca35 8.9 1 4.7 0.6
25.7 2 12.8 97.0
34.2 3 6.7 2.4
P50Na10Ti5Ca31.5Sr3.5 8.7 1 4.9 5.8
25.6 2 12.6 96.3
33.8 3 6.2 1.2
P50Na10Ti5Ca17.5Sr17.5 8.4 1 5.2 3.9
24.9 2 12.3 95.7
33.6 3 5.8 0.4
P50Na10Ti5Sr35 8.3 1 5.6 5.9
23.6 2 11.6 94.1
8.9 1 4.7 0.6
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Figure 4. FTIR spectra of Ti-stabilised phosphate-based glasses
with varying Ca and Sr content. Broad peaks at 740, 900, 980,
1100 and 1250 cm1 can be assigned to s (P–O–P), as (P–O–P),
s (PO3)
2, as (PO3)
2 and as (PO2)
, respectively.
Table 4. Infrared band assignment for sol–gel glasses
(, stretching; s, symmetric; as, asymmetric).
Wavenumber (cm1) Assignments Associated Qi
740 s (P–O–P) N/A
900 as (P–O–P) Q
2
980 s (PO3)
2 Q1
1100 as (PO3)
2 Q1
1250 as (PO2) Q
2
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correlated directly with Ca content in the glass. A small
amount of Ca2þ was, however, released from Sr35.
Similarly to Na2þ, polyphosphate ion release was inver-
sely proportional to Sr content. PO34 appeared to be
least aﬀected by Sr content, while P2O
4
7 exhibited the
greatest magnitude in reduction as Sr content was
increased. The concentration of P3O
3
9 and P3O
5
10
present in solution exhibited a clear reduction as
Sr was increased.
Cytocompatibility and ALP activity
All glass compositions had high cytocompatibility
(Figure 9(a)). After one and four days, cells cultured
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Figure 7. Cumulative release of cations (a) Naþ, (b) Ca2þ and (c) Sr2þ from Ti-stabilised phosphate-based glasses with varying Ca
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on all glass compositions had comparable metabolic
activity compared to cells cultured on TCP. Between
seeding and day 1, cells approximately doubled in
number from 30,000 to 70,000 cells/cm2. By day 4,
they had roughly doubled again to 135,000 cells/cm2.
After seven days, the apparent cell density on
Sr0 (240,000 cells/cm2) was similar to TCP (262,000
cells/cm2) and slightly higher than the other glass com-
positions (206,000–217,000 cells/cm2). By day 14, the
density of cells on TCP had dropped slightly, whereas
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the number of surviving cells on glass compositions fell
by between 13 and 48%. The greatest reduction in cell
number was observed on Sr17.5.
The ALP activity (Figure 9(b)) of cells cultured on
glass discs was higher at all time points than on TCP.
ALP activity of cells cultured on glass discs was similar
after four and seven days, regardless of composition.
After 14 days, however, despite Sr17.5 causing a
decrease in overall metabolic activity, the normalised
ALP activity was approximately double that of the
other compositions.
Discussion
Research in our group focuses on the development of
phosphate-based glasses for tissue engineering applica-
tions. Several studies leading up to the present work
have investigated the incorporation of Sr in phos-
phate-based melt-quench glasses. An initial study
revealed that tertiary and quaternary glasses with
the formula (P2O5)50–(Na2O)(20-x)–(CaO)(30)–(SrO)(x)
(x¼ 0, 1, 3 or 5) (mol%) suﬀered from poor cytocom-
patibility due to their rapid degradation rate.8 In a
follow-up study, incorporation of 3mol% Ti in quater-
nary and quinternary (P2O5)50–(Na2O)17–(TiO2)3–
(CaO)(30-x)–(SrO)(x) (x¼ 0, 1, 3 or 5) (mol%) glasses
was shown to prolong the degradation rate and
improve cytocompatibility compared to Ti-free com-
positions.9 The substitution of CaO with SrO, however,
resulted in an increase in dissolution rate, but with an
inverse trend, whereby increasing Sr content had a less
pronounced eﬀect, as follows: Sr0<Sr5< Sr3< Sr1.
This directly correlated with a decrease in cytocompat-
ibility, with Sr0 best supporting cell growth:
Sr0> Sr5>Sr3> Sr1. These unusual but distinctive
trends indicated the likelihood of systematic – rather
than random – alterations to the glass network.
Subsequently, (P2O5)50–(Na2O)15–(TiO2)5–(CaO)(30-x)–
(SrO)(x) (x¼ 0, 1, 3 or 5) (mol%) compositions, in
which Ti content was increased to 5mol%, were
shown to have 2–4 times lower degradation rates than
those containing 3mol% Ti.6 The slower dissolution
rate also fostered improved cell attachment. Again,
degradation was highest in the composition with
low Sr content, reaﬃrming the prominent
Sr0< Sr5<Sr3< Sr1 trend observed previously.
More comprehensive analyses of the physical char-
acteristics of glasses with higher Sr and Ti content were
performed within the present study. Phosphate-based
glasses containing up to 35mol% Sr were successfully
prepared. As previously observed,8 glass density was
shown to increase as a function of Sr content. This
correlates with the signiﬁcantly higher density of Sr
(2.64 g/cm3) compared to Ca (1.54 g/cm3). The glasses
were also shown to be amorphous and to
predominantly consist of Q2 phosphate units, which
slightly decreased as Sr content was increased. In add-
ition, the small peak at around 34 ppm, which corres-
ponds to Q3 species, was not present in Sr35. With
regards to the FTIR data, as Ca was substituted with
Sr, a reduction in the intensity of the peak at 900 cm1
(Q2 species) and an increase in the intensity of the peak
at 1100 cm1 (Q1 species) indicated a move to a more
disordered structure. This is likely due to the larger
ionic radius of Sr compared to Ca. Furthermore,
DTA results conﬁrmed a signiﬁcant reduction in the
Tc value as Sr content was increased.
The glass discs were immersed in deionised water for
zero, one, four, seven and 14 days and their degrad-
ation was analysed by ion chromatography and by
measuring the pH change of the water. The use of ion
chromatography was favoured over that of inductively
coupled plasma spectroscopy, due to its ability to dif-
ferentiate between diﬀerent phosphate species. This is a
particularly important factor when studying the dissol-
ution of glasses in which phosphate is a major compo-
nent. Due to the presence of organic solvents which
interfere with the ion chromatography column, the
use of Tris–HCl was selected against. Phosphate
buﬀered saline, which contains high phosphate
concentration, as well as simulated body ﬂuid, which
is super-saturated with the same ions as those released
from the glasses, was also discounted, as the concentra-
tion of released ions would have been indistinguishable
from the high background levels.
The detection of a small amount of Ca2þ release
from Sr35, which should not have contained any Ca,
is likely due to impurity of the Sr precursor, which has a
purity of 98.5% and contains up to 0.07% Ca. With
increasing Sr content, the mass loss at any given time
point increased. Overall, there should have been no
major change in the glass structure as the Sr2þ replaces
the similarly charged Ca2þ. Thus, the overall mass loss
may be explained by the diﬀerence in the atomic weight
between these two divalent cations. The inclusion of a
larger ionic radius cation may make the glass network
more susceptible to hydrolysis. The Naþ release diﬀered
in that as Sr2þ content was increased, Naþ release
decreased. The same is seen for PO4
3, and indeed all
the phosphate species measured, and it may be that the
Naþ and PO4
3 are reacting once released into solu-
tion, making them unavailable for measurement by
ion chromatography. Further to this point, the stark
reduction in P2O7
4 and P3O10
5 species may be
expected, given their high stability constants (i.e. their
ability to chelate divalent cationic species).33 The asser-
tion that Sr2þ release favours mineralisation processes
is, to some extent, supported by the pH change data.
All glass formulations were shown to have good
cytocompatibility. The apparent cell density after one
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and four days was similar in all formulations and the TCP
control. After seven days, the apparent density of cells
surviving on Sr-containing glass discs was 20% lower
than on TCP or Sr0, but still remained high, at around
seven times the original seeding density. By 14 days, the
apparent cell density on all samples and TCP had
dropped slightly, except Sr17.5, which had halved in
number compared to day 7. The ALP activity of cells
cultured on glass discs of all compositions was approxi-
mately double that of the control at each time point. The
one exception to this was Sr17.5, which induced similar
ALP activity per cell to other glass formulations at all
time points except day 14, by which time it had doubled.
This was in spite of the lower apparent cell density on
Sr17.5 at 14 days. The decrease in WST-8 metabolism of
cells cultured on Sr17.5 is likely caused by the simultan-
eous increase in ALP activity, rather than an actual reduc-
tion in cell density. The higher ALP activity of cells
cultured on Sr17.5 ﬁts with previous data concerning
the optimal concentration of Sr for induction of osteo-
genic diﬀerentiation of bone marrow stromal cells.34 A
concentration of 5mg/ml SrCl2 was shown to induce
higher levels of COL1A1 expression and calciﬁed matrix
deposition than 1 or 10mg/ml. In the present study, the
concentration of Sr2þ in extracts of Sr0, Sr3.5, Sr17.5 and
Sr35 after 14 days was 0.0, 1.1, 4.5 and 8.1mg/ml, respect-
ively. The concentration of Sr2þ released from Sr35 is
therefore higher than optimal and explains the lower
ALP activity induced by Sr35 than Sr17.5.
In summary, all glass compositions induced at least
2.3-fold and up to 3.6-fold higher ALP activity than the
control at all time points. Furthermore, the cytocom-
patibility of all formulations was shown to be high.
This, combined with their controllable degradation
rate, demonstrates the potential of Sr- and Ti-contain-
ing phosphate-based glasses for the treatment of osteo-
porosis, fractures and other orthopaedic, maxillofacial
and dental applications.
Conclusions
Sr- and Ca-containing Ti-stabilised phosphate-based
glasses were successfully prepared via the facile melt-
quench technique. The materials had an ideal degrad-
ation rate for tissue engineering applications, due to the
incorporation of Ti, which forms stable crosslinks in
the glass network. The glasses also induced between
2.3- and 3.6-fold increase in ALP activity, relative to
the control, with Sr17.5 causing the greatest increase,
and all compositions had good cytocompatibility. This
was likely due to their Ca and Sr content, which are
both widely known to support osteoinduction and
osteogenesis. In conclusion, Ti-stabilised, Ca- and Sr-
releasing phosphate-based glasses have great potential
in the treatment of fractures induced by osteoporosis,
congenital bone defects and injury, as well as in other
orthopaedic, maxillofacial and dental tissue engineering
applications.
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